Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases.
Saved in:
| Title: | Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases. |
|---|---|
| Authors: | Sofianidi AA; Oncology Unit, Aretaieion University Hospital, National and Kapodistrian University of Athens School of Medicine, Vasilissis Sofias 76, Athens, 115 28, Greece. amaliasof@med.uoa.gr., Panagodimou E; Second Department of Obstetrics and Gynecology, Aretaieion University Hospital, National and Kapodistrian University of Athens, Athens, 11527, Greece., Kalampokas E; Second Department of Obstetrics and Gynecology, Aretaieion University Hospital, National and Kapodistrian University of Athens, Athens, 11527, Greece., Georgakopoulos I; Radiation Oncology Unit, First Department of Radiology, Medical School, Aretaieion Hospital, National and Kapodistrian University of Athens, 11527, Athens, Greece., Zagouri F; Oncology Unit, Aretaieion University Hospital, National and Kapodistrian University of Athens School of Medicine, Vasilissis Sofias 76, Athens, 115 28, Greece. |
| Source: | Current oncology reports [Curr Oncol Rep] 2026 Jun 22; Vol. 28 (1). Date of Electronic Publication: 2026 Jun 22. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6269 (Electronic) Linking ISSN: 15233790 NLM ISO Abbreviation: Curr Oncol Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
